Theralase Financial Statements From 2010 to 2026

Stocks . Canada . 
Stock . Theralase Technologies
TLT Stock  CAD 0.30  0.03  11.11%   
Theralase Technologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Theralase Technologies' valuation are provided below:
Gross Profit
554 K
Market Capitalization
71.5 M
Enterprise Value Revenue
71.6911
Revenue
1 M
Earnings Share
(0.02)
There are over one hundred nineteen available fundamental trend indicators for Theralase Technologies, which can be analyzed over time and compared to other ratios. All traders should should double-check Theralase Technologies' current fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to climb to about 60.1 M in 2026. Enterprise Value is likely to climb to about 60.1 M in 2026

Theralase Technologies Total Revenue

1.52 Million

Check Theralase Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 345.5 K, Interest Expense of 29.1 K or Other Operating Expenses of 4.2 M, as well as many indicators such as Price To Sales Ratio of 67.25, Dividend Yield of 2.16 or PTB Ratio of 37.16. Theralase financial statements analysis is a perfect complement when working with Theralase Technologies Valuation or Volatility modules.
  
This module can also supplement various Theralase Technologies Technical models . Check out the analysis of Theralase Technologies Correlation against competitors.

Theralase Technologies Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.4 M3.7 M4.7 M
Slightly volatile
Total Current Liabilities813.4 K1.1 M978.6 K
Pretty Stable
Property Plant And Equipment Net433.2 K696.7 K583.9 K
Slightly volatile
Accounts Payable455.8 K416.5 K481 K
Pretty Stable
Cash293.6 K309.1 K2.3 M
Very volatile
Non Current Assets Total1.3 M1.9 M930.8 K
Slightly volatile
Cash And Short Term Investments48 K50.5 K2.3 M
Very volatile
Common Stock Shares Outstanding299.2 M284.9 M147.1 M
Slightly volatile
Liabilities And Stockholders Equity4.4 M3.8 M4.7 M
Slightly volatile
Other Stockholder Equity7.8 M14.4 M7.9 M
Slightly volatile
Total Liabilities877.3 K1.4 M1.1 M
Slightly volatile
Total Current Assets3.1 M1.8 M3.8 M
Pretty Stable
Accumulated Other Comprehensive Income3.9 M7.2 M3.9 M
Slightly volatile
Short and Long Term Debt Total467.2 K444.9 K193.4 K
Slightly volatile
Other Current Liabilities286.4 K347.9 K349.9 K
Pretty Stable
Net Receivables182.1 K191.7 K570.6 K
Slightly volatile
Inventory505.4 K626.8 K573.5 K
Slightly volatile
Other Current Assets126.9 K67.1 K140.4 K
Very volatile
Short Term Debt65.3 K107 K130.7 K
Pretty Stable
Intangible Assets5.6 K5.9 K46.4 K
Slightly volatile
Short Term Investments285.4 K283.1 K315.9 K
Slightly volatile
Good Will1.5 M1.7 M1.8 M
Slightly volatile
Common Stock29.7 M53.4 M28.7 M
Slightly volatile
Net Tangible Assets5.6 M3.6 M4.2 M
Slightly volatile
Other Assets668.1 K636.2 K223.5 K
Slightly volatile
Short and Long Term Debt22.5 K25.3 K27.6 K
Slightly volatile
Property Plant Equipment775.8 K1.3 M704.7 K
Slightly volatile
Net Invested Capital1.8 M1.9 M3.3 M
Pretty Stable
Net Working Capital511 K537.9 K2.3 M
Very volatile
Capital Stock46 M56.3 M35.7 M
Slightly volatile
Capital Lease Obligations261.6 K337.9 K195.8 K
Slightly volatile
Property Plant And Equipment Gross2.3 M2.4 M2.2 M
Pretty Stable

Theralase Technologies Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense29.1 K27.8 K16 K
Pretty Stable
Other Operating Expenses4.2 M6.5 M5.3 M
Slightly volatile
Total Operating Expenses3.7 M6.1 M4.7 M
Slightly volatile
Total Revenue1.5 M1.2 M1.4 M
Pretty Stable
Gross Profit671.9 K498.6 K731.8 K
Slightly volatile
Cost Of Revenue621.8 K551.3 K600.8 K
Slightly volatile
Selling General Administrative2 M2.4 M1.9 M
Slightly volatile
Selling And Marketing Expenses83.1 K87.5 K570.1 K
Slightly volatile
Research Development2.2 M3.2 M2.3 M
Slightly volatile
Net Interest Income29.8 K48.7 K24.3 K
Slightly volatile
Interest Income42.5 K76.4 K32.9 K
Slightly volatile
Reconciled Depreciation295.9 K312.9 K267 K
Slightly volatile

Theralase Technologies Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow48 K50.5 K2.3 M
Pretty Stable
End Period Cash Flow293.6 K309.1 K2.3 M
Very volatile
Depreciation181.2 K312.9 K188 K
Slightly volatile
Stock Based Compensation371.1 K599.3 K376.6 K
Slightly volatile
Sale Purchase Of Stock2.6 M1.8 M2.3 M
Pretty Stable
Change To Netincome441.1 K277.2 K330.2 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio67.2570.79241
Slightly volatile
Dividend Yield2.162.432.6524
Slightly volatile
Days Sales Outstanding213289242
Slightly volatile
Average Payables302.9 K454.5 K421.5 K
Pretty Stable
Stock Based Compensation To Revenue0.480.450.3128
Slightly volatile
Capex To Depreciation0.08020.08442.7722
Slightly volatile
EV To Sales67.2870.82237
Slightly volatile
Inventory Turnover1.671.011.2008
Pretty Stable
Days Of Inventory On Hand417477469
Pretty Stable
Payables Turnover1.461.521.2565
Pretty Stable
Sales General And Administrative To Revenue1.031.691.3872
Slightly volatile
Average Inventory339.2 K541.5 K541.5 K
Slightly volatile
Research And Ddevelopement To Revenue1.342.41.8717
Slightly volatile
Capex To Revenue0.02110.02220.2011
Slightly volatile
Cash Per Share0.0010.0010.0181
Pretty Stable
Days Payables Outstanding393317399
Slightly volatile
Income Quality1.10.90.8412
Pretty Stable
Intangibles To Total Assets5.0E-45.0E-40.026
Slightly volatile
Current Ratio1.751.854.9477
Slightly volatile
Receivables Turnover1.591.672.476
Very volatile
Capex Per Share1.0E-41.0E-40.0014
Slightly volatile
Average Receivables374.1 K589.5 K581.9 K
Very volatile
Revenue Per Share0.00470.0050.0144
Slightly volatile
Interest Debt Per Share0.00120.00158.0E-4
Slightly volatile
Debt To Assets0.08550.08150.0453
Pretty Stable
Graham Number0.04070.03450.0317
Very volatile
Operating Cycle629766712
Slightly volatile
Days Of Payables Outstanding393317399
Slightly volatile
Quick Ratio1.151.214.3205
Slightly volatile
Cash Ratio0.30.313.3955
Slightly volatile
Days Of Inventory Outstanding417477469
Pretty Stable
Days Of Sales Outstanding213289242
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.161.0876
Pretty Stable
Fixed Asset Turnover1.861.964.0847
Slightly volatile
Debt Ratio0.08550.08150.0453
Pretty Stable
Price Sales Ratio67.2570.79241
Slightly volatile
Asset Turnover0.510.370.4553
Slightly volatile
Gross Profit Margin0.650.620.5397
Pretty Stable

Theralase Technologies Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.1 M57.3 M40.6 M
Slightly volatile
Enterprise Value60.1 M57.3 M38.4 M
Slightly volatile

About Theralase Technologies Financial Statements

Theralase Technologies investors use historical fundamental indicators, such as Theralase Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theralase Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.5 M
Total Revenue1.2 M1.5 M
Cost Of Revenue551.3 K621.8 K
Stock Based Compensation To Revenue 0.45  0.48 
Sales General And Administrative To Revenue 1.69  1.03 
Research And Ddevelopement To Revenue 2.40  1.34 
Capex To Revenue 0.02  0.02 
Ebit Per Revenue(4.77)(4.53)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Theralase Stock Analysis

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY